Axonics (AXNX) Revenue & Revenue Breakdown
Axonics Revenue Highlights
Latest Revenue (Y)
$366.38M
Latest Revenue (Q)
$116.19M
Main Segment (Y)
Sacral Neuromodulation
Main Geography (Y)
UNITED STATES
Axonics Revenue by Period
Axonics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $366.38M | 33.86% |
| 2022-12-31 | $273.70M | 51.81% |
| 2021-12-31 | $180.29M | 61.64% |
| 2020-12-31 | $111.53M | 707.05% |
| 2019-12-31 | $13.82M | 1854.74% |
| 2018-12-31 | $707.00K | 451.84% |
| 2017-12-31 | $128.12K | 100.00% |
| 2016-12-31 | - | - |
Axonics generated $366.38M in revenue during NA 2023, up 33.86% compared to the previous quarter, and up 51821.64% compared to the same period a year ago.
Axonics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $116.19M | 1.42% |
| 2024-06-30 | $114.56M | 25.33% |
| 2024-03-31 | $91.41M | -16.70% |
| 2023-12-31 | $109.73M | 17.87% |
| 2023-09-30 | $93.10M | 310.06% |
| 2023-06-30 | $22.70M | -67.86% |
| 2023-03-31 | $70.65M | -17.77% |
| 2022-12-31 | $85.92M | 22.07% |
| 2022-09-30 | $70.38M | 2.04% |
| 2022-06-30 | $68.98M | 42.46% |
| 2022-03-31 | $48.42M | -8.87% |
| 2021-12-31 | $53.13M | 13.26% |
| 2021-09-30 | $46.91M | 2.28% |
| 2021-06-30 | $45.87M | 33.44% |
| 2021-03-31 | $34.37M | -1.18% |
| 2020-12-31 | $34.78M | -1.31% |
| 2020-09-30 | $35.24M | 131.66% |
| 2020-06-30 | $15.21M | -42.15% |
| 2020-03-31 | $26.30M | 164.39% |
| 2019-12-31 | $9.95M | 659.82% |
| 2019-09-30 | $1.31M | -12.03% |
| 2019-06-30 | $1.49M | 38.16% |
| 2019-03-31 | $1.08M | 118.02% |
| 2018-12-31 | $494.00K | 145.77% |
| 2018-09-30 | $201.00K | 1575.00% |
| 2018-06-30 | $12.00K | 100.00% |
| 2018-03-31 | - | -100.00% |
| 2017-12-31 | $118.00 | -99.91% |
| 2017-09-30 | $128.00K | 100.00% |
| 2017-06-30 | - | 100.00% |
| 2017-03-31 | - | - |
Axonics generated $116.19M in revenue during Q3 2024, up 1.42% compared to the previous quarter, and up 511.77% compared to the same period a year ago.
Axonics Revenue Breakdown
Axonics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 |
|---|---|
| Sacral Neuromodulation | $291.81M |
| Bulkamid | $74.57M |
Axonics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Sacral Neuromodulation (79.65%), and Bulkamid (20.35%).
Quarterly Revenue by Product
| Product/Service | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 21 | Mar 21 |
|---|---|---|---|---|---|---|---|
| Sacral Neuromodulation | $92.35M | $91.22M | $71.68M | $217.86M | $73.95M | $40.19M | $32.90M |
| Bulkamid | $23.84M | $23.35M | $19.73M | $55.42M | $19.15M | $5.67M | $1.47M |
Axonics's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Sacral Neuromodulation (79.48%), and Bulkamid (20.52%).
Axonics Revenue Breakdown by Country
Annual Revenue by Country
| Country | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Non-US | $15.54M | $5.13M | $3.75M | $3.99M | $5.44M |
| UNITED STATES | $284.85M | $216.86M | $153.84M | $107.54M | $8.38M |
Axonics's latest annual revenue breakdown by geography, as of Dec 23: UNITED STATES (94.83%), and Non-US (5.17%).
Quarterly Revenue by Country
| Country | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $90.07M | $89.08M | $69.84M | $86.58M | $72.21M | $72.20M | $53.85M | $69.07M | $55.61M | $54.47M | $37.72M | $43.70M | $39.15M | $41.61M | $32.32M | $33.71M | $34.14M | $14.65M | $25.05M |
| Non-US | $4.79M | $5.04M | $4.51M | $8.68M | $3.57M | $1.98M | $1.30M | $1.24M | $1.25M | $1.29M | $1.35M | $722.00K | $922.00K | $4.25M | $2.05M | $1.07M | $1.10M | $565.00K | $1.25M |
Axonics's latest quarterly revenue breakdown by geography, as of Sep 24: UNITED STATES (94.95%), and Non-US (5.05%).
Axonics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| MDT | Medtronic | $32.36B | $8.40B |
| BRKR | Bruker | $2.96B | $800.70M |
| ITGR | Integer | $1.60B | $746.27M |
| IART | Integra LifeSciences | $1.54B | $380.83M |
| CNMD | CONMED | $1.24B | $316.70M |
| LIVN | LivaNova | $1.15B | $318.11M |
| IRTC | iRhythm | $492.68M | $147.54M |
| AXNX | Axonics | $366.38M | $116.19M |
| GKOS | Glaukos | $314.71M | $96.67M |
| KIDS | OrthoPediatrics | $148.73M | $52.80M |
| SIBN | SI-BONE | $138.89M | $40.34M |
| LUNG | Pulmonx | $68.67M | $20.39M |
| NPCE | NeuroPace | $65.42M | $21.06M |
| NNOX | Nano-X Imaging | $9.90M | $2.55M |
| MGRM | Monogram Orthopaedics | $365.00K | - |
| OFIX | Orthofix Medical | $100.00K | $198.62M |